LEGN Stock Analysis: Buy, Sell, or Hold?
LEGN - Legend Biotech Corporation American Depositary Shares
$18.55
-0.50 (-2.62%)
▼
5d:
-16.52%
30d:
-37.94%
90d:
-21.13%
WAIT
LOW Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 11, 2026
8d
Get Alerted When LEGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: LEGN is down 16.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: LEGN is down 16.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$58.72
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$36.46
49.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: LEGN is currently trading at $18.55, which is considered oversold relative to its 30-day fair value range of $21.44 to $29.01. From a valuation perspective, the stock is trading at a discount (Forward PE: 15.4) compared to its historical average (35.1). Remarkably, the market is currently pricing in an annual earnings decline of 24.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, LEGN is in a uptrend. The price is currently testing key support at $18.33. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $52.10 (+180.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, LEGN is in a uptrend. The price is currently testing key support at $18.33. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $52.10 (+180.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$21.44 -
$29.01
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 180.9% below Wall St target ($52.10)
- WARNING: Recommendation downgraded due to -16.5% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$21.44 -
$29.01
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$18.33
Resistance Level
$24.05
Current Trend
Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
15.38
Wall Street Target
$52.10
(+180.9%)
Revenue Growth (YoY)
56.5%
Profit Margin
-22.0%
Valuation Discount vs History
-24.0% cheaper
PE vs Historical
15.4 vs 35.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-24.0%
(market-implied from PE analysis)
1-Year Target
$16.70
(-10%)
2-Year Target
$15.03
(-19%)
3-Year Target
$13.52
(-27%)
3-Yr Target (if PE normalizes)
(PE: 15→35)
$30.86
(+66%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 330.8%)
$84.39
(+355%)
Base:
(SPY PE: 15.4, Growth: 330.8%)
$62.61
(+238%)
Bear:
(PE: 13.1, Growth: 330.8%)
$53.22
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 15.4 to 35.1
Stabilization Target:
$42.34
(+128.2%)
PE Expansion Potential:
+128.2%
Share & Embed Analysis
Last updated: August 02, 2026 6:32 PM ET
Data refreshes hourly during market hours. Next update: 7:32 PM
Data refreshes hourly during market hours. Next update: 7:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is LEGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Ying Huang
SELL
9936 shares
2026-03-25
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$416 | 53 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$386 | 43 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$557 | 49 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 54 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 47 HOLD |
